Company Profile

Company Description

Nurix Therapeutics is a biopharmaceutical firm focused on developing innovative therapies targeting protein regulation to treat cancer and immune disorders. Utilizing its proprietary drug discovery platform, the company designs molecules that modulate E3 ligases, aiming to degrade or stabilize disease-causing proteins. Its pipeline includes both small-molecule inhibitors and protein degraders, with several candidates in clinical trials. The company collaborates with leading pharmaceutical partners to advance its research and expand therapeutic applications. Nurix is committed to addressing unmet medical needs through groundbreaking science and precision medicine approaches.